nodes	percent_of_prediction	percent_of_DWPC	metapath
Perflutren—Sevoflurane—CYP2A6—lung cancer	0.0103	0.476	CrCbGaD
Perflutren—Sevoflurane—CYP2E1—lung cancer	0.00734	0.338	CrCbGaD
Perflutren—Sevoflurane—ALB—lung cancer	0.00403	0.186	CrCbGaD
Perflutren—Nervous system disorder—Paclitaxel—lung cancer	0.000609	0.000623	CcSEcCtD
Perflutren—Tachycardia—Paclitaxel—lung cancer	0.000606	0.00062	CcSEcCtD
Perflutren—Skin disorder—Paclitaxel—lung cancer	0.000603	0.000617	CcSEcCtD
Perflutren—Abdominal pain—Irinotecan—lung cancer	0.000602	0.000615	CcSEcCtD
Perflutren—Body temperature increased—Irinotecan—lung cancer	0.000602	0.000615	CcSEcCtD
Perflutren—Hyperhidrosis—Paclitaxel—lung cancer	0.0006	0.000614	CcSEcCtD
Perflutren—Gastrointestinal disorder—Cisplatin—lung cancer	0.000597	0.00061	CcSEcCtD
Perflutren—Hypotension—Etoposide—lung cancer	0.000592	0.000605	CcSEcCtD
Perflutren—Pain—Cisplatin—lung cancer	0.000591	0.000604	CcSEcCtD
Perflutren—Vomiting—Vinorelbine—lung cancer	0.000587	0.0006	CcSEcCtD
Perflutren—Body temperature increased—Gemcitabine—lung cancer	0.000586	0.000599	CcSEcCtD
Perflutren—Rash—Vinorelbine—lung cancer	0.000582	0.000595	CcSEcCtD
Perflutren—Dermatitis—Vinorelbine—lung cancer	0.000582	0.000595	CcSEcCtD
Perflutren—Hypotension—Paclitaxel—lung cancer	0.00058	0.000593	CcSEcCtD
Perflutren—Headache—Vinorelbine—lung cancer	0.000579	0.000591	CcSEcCtD
Perflutren—Syncope—Docetaxel—lung cancer	0.000579	0.000591	CcSEcCtD
Perflutren—Conjunctivitis—Methotrexate—lung cancer	0.000578	0.000591	CcSEcCtD
Perflutren—Leukopenia—Docetaxel—lung cancer	0.000577	0.00059	CcSEcCtD
Perflutren—Eosinophilia—Doxorubicin—lung cancer	0.000572	0.000585	CcSEcCtD
Perflutren—Palpitations—Docetaxel—lung cancer	0.00057	0.000583	CcSEcCtD
Perflutren—Feeling abnormal—Cisplatin—lung cancer	0.00057	0.000582	CcSEcCtD
Perflutren—Paraesthesia—Etoposide—lung cancer	0.000569	0.000581	CcSEcCtD
Perflutren—Loss of consciousness—Docetaxel—lung cancer	0.000567	0.00058	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000566	0.000578	CcSEcCtD
Perflutren—Dyspnoea—Etoposide—lung cancer	0.000565	0.000577	CcSEcCtD
Perflutren—Cough—Docetaxel—lung cancer	0.000563	0.000575	CcSEcCtD
Perflutren—Hypersensitivity—Irinotecan—lung cancer	0.000561	0.000574	CcSEcCtD
Perflutren—Convulsion—Docetaxel—lung cancer	0.000559	0.000571	CcSEcCtD
Perflutren—Paraesthesia—Paclitaxel—lung cancer	0.000558	0.00057	CcSEcCtD
Perflutren—Hypertension—Docetaxel—lung cancer	0.000557	0.000569	CcSEcCtD
Perflutren—Dyspnoea—Paclitaxel—lung cancer	0.000554	0.000566	CcSEcCtD
Perflutren—Chest pain—Docetaxel—lung cancer	0.000549	0.000561	CcSEcCtD
Perflutren—Arthralgia—Docetaxel—lung cancer	0.000549	0.000561	CcSEcCtD
Perflutren—Myalgia—Docetaxel—lung cancer	0.000549	0.000561	CcSEcCtD
Perflutren—Nausea—Vinorelbine—lung cancer	0.000549	0.000561	CcSEcCtD
Perflutren—Gastrointestinal disorder—Etoposide—lung cancer	0.000547	0.000559	CcSEcCtD
Perflutren—Dyspepsia—Paclitaxel—lung cancer	0.000547	0.000559	CcSEcCtD
Perflutren—Body temperature increased—Cisplatin—lung cancer	0.000547	0.000559	CcSEcCtD
Perflutren—Asthenia—Irinotecan—lung cancer	0.000546	0.000559	CcSEcCtD
Perflutren—Fatigue—Etoposide—lung cancer	0.000546	0.000558	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000545	0.000558	CcSEcCtD
Perflutren—Pain—Etoposide—lung cancer	0.000542	0.000554	CcSEcCtD
Perflutren—Dry mouth—Docetaxel—lung cancer	0.000537	0.000549	CcSEcCtD
Perflutren—Haemoglobin—Methotrexate—lung cancer	0.000537	0.000549	CcSEcCtD
Perflutren—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000536	0.000548	CcSEcCtD
Perflutren—Fatigue—Paclitaxel—lung cancer	0.000536	0.000547	CcSEcCtD
Perflutren—Haemorrhage—Methotrexate—lung cancer	0.000534	0.000546	CcSEcCtD
Perflutren—Asthenia—Gemcitabine—lung cancer	0.000532	0.000544	CcSEcCtD
Perflutren—Pain—Paclitaxel—lung cancer	0.000531	0.000543	CcSEcCtD
Perflutren—Pharyngitis—Methotrexate—lung cancer	0.00053	0.000542	CcSEcCtD
Perflutren—Anaphylactic shock—Docetaxel—lung cancer	0.000526	0.000538	CcSEcCtD
Perflutren—Oedema—Docetaxel—lung cancer	0.000526	0.000538	CcSEcCtD
Perflutren—Pruritus—Gemcitabine—lung cancer	0.000525	0.000537	CcSEcCtD
Perflutren—Feeling abnormal—Etoposide—lung cancer	0.000522	0.000534	CcSEcCtD
Perflutren—Diarrhoea—Irinotecan—lung cancer	0.000521	0.000533	CcSEcCtD
Perflutren—Gastrointestinal pain—Etoposide—lung cancer	0.000518	0.00053	CcSEcCtD
Perflutren—Shock—Docetaxel—lung cancer	0.000518	0.000529	CcSEcCtD
Perflutren—Nervous system disorder—Docetaxel—lung cancer	0.000516	0.000528	CcSEcCtD
Perflutren—Visual impairment—Methotrexate—lung cancer	0.000515	0.000526	CcSEcCtD
Perflutren—Tachycardia—Docetaxel—lung cancer	0.000514	0.000525	CcSEcCtD
Perflutren—Feeling abnormal—Paclitaxel—lung cancer	0.000512	0.000523	CcSEcCtD
Perflutren—Skin disorder—Docetaxel—lung cancer	0.000511	0.000523	CcSEcCtD
Perflutren—Hypersensitivity—Cisplatin—lung cancer	0.000509	0.000521	CcSEcCtD
Perflutren—Gastrointestinal pain—Paclitaxel—lung cancer	0.000508	0.000519	CcSEcCtD
Perflutren—Diarrhoea—Gemcitabine—lung cancer	0.000508	0.000519	CcSEcCtD
Perflutren—Neuropathy peripheral—Doxorubicin—lung cancer	0.000505	0.000516	CcSEcCtD
Perflutren—Dizziness—Irinotecan—lung cancer	0.000504	0.000515	CcSEcCtD
Perflutren—Urticaria—Etoposide—lung cancer	0.000503	0.000514	CcSEcCtD
Perflutren—Body temperature increased—Etoposide—lung cancer	0.000501	0.000512	CcSEcCtD
Perflutren—Abdominal pain—Etoposide—lung cancer	0.000501	0.000512	CcSEcCtD
Perflutren—Conjunctivitis—Doxorubicin—lung cancer	0.000501	0.000512	CcSEcCtD
Perflutren—Eye disorder—Methotrexate—lung cancer	0.000499	0.00051	CcSEcCtD
Perflutren—Tinnitus—Methotrexate—lung cancer	0.000498	0.000509	CcSEcCtD
Perflutren—Asthenia—Cisplatin—lung cancer	0.000496	0.000507	CcSEcCtD
Perflutren—Cardiac disorder—Methotrexate—lung cancer	0.000496	0.000507	CcSEcCtD
Perflutren—Urticaria—Paclitaxel—lung cancer	0.000493	0.000504	CcSEcCtD
Perflutren—Hypotension—Docetaxel—lung cancer	0.000492	0.000503	CcSEcCtD
Perflutren—Abdominal pain—Paclitaxel—lung cancer	0.000491	0.000502	CcSEcCtD
Perflutren—Body temperature increased—Paclitaxel—lung cancer	0.000491	0.000502	CcSEcCtD
Perflutren—Angiopathy—Methotrexate—lung cancer	0.000485	0.000495	CcSEcCtD
Perflutren—Vomiting—Irinotecan—lung cancer	0.000484	0.000495	CcSEcCtD
Perflutren—Immune system disorder—Methotrexate—lung cancer	0.000482	0.000493	CcSEcCtD
Perflutren—Mediastinal disorder—Methotrexate—lung cancer	0.000481	0.000492	CcSEcCtD
Perflutren—Rash—Irinotecan—lung cancer	0.00048	0.000491	CcSEcCtD
Perflutren—Dermatitis—Irinotecan—lung cancer	0.00048	0.00049	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Docetaxel—lung cancer	0.00048	0.00049	CcSEcCtD
Perflutren—Chills—Methotrexate—lung cancer	0.000479	0.00049	CcSEcCtD
Perflutren—Headache—Irinotecan—lung cancer	0.000477	0.000488	CcSEcCtD
Perflutren—Diarrhoea—Cisplatin—lung cancer	0.000473	0.000484	CcSEcCtD
Perflutren—Paraesthesia—Docetaxel—lung cancer	0.000473	0.000483	CcSEcCtD
Perflutren—Vomiting—Gemcitabine—lung cancer	0.000472	0.000482	CcSEcCtD
Perflutren—Bradycardia—Doxorubicin—lung cancer	0.000471	0.000481	CcSEcCtD
Perflutren—Dyspnoea—Docetaxel—lung cancer	0.000469	0.00048	CcSEcCtD
Perflutren—Rash—Gemcitabine—lung cancer	0.000468	0.000478	CcSEcCtD
Perflutren—Dermatitis—Gemcitabine—lung cancer	0.000467	0.000478	CcSEcCtD
Perflutren—Hypersensitivity—Etoposide—lung cancer	0.000467	0.000477	CcSEcCtD
Perflutren—Erythema—Methotrexate—lung cancer	0.000465	0.000475	CcSEcCtD
Perflutren—Haemoglobin—Doxorubicin—lung cancer	0.000465	0.000475	CcSEcCtD
Perflutren—Headache—Gemcitabine—lung cancer	0.000465	0.000475	CcSEcCtD
Perflutren—Rhinitis—Doxorubicin—lung cancer	0.000464	0.000474	CcSEcCtD
Perflutren—Dyspepsia—Docetaxel—lung cancer	0.000463	0.000474	CcSEcCtD
Perflutren—Haemorrhage—Doxorubicin—lung cancer	0.000462	0.000473	CcSEcCtD
Perflutren—Hypoaesthesia—Doxorubicin—lung cancer	0.00046	0.00047	CcSEcCtD
Perflutren—Pharyngitis—Doxorubicin—lung cancer	0.000459	0.000469	CcSEcCtD
Perflutren—Hypersensitivity—Paclitaxel—lung cancer	0.000458	0.000468	CcSEcCtD
Perflutren—Dysgeusia—Methotrexate—lung cancer	0.000455	0.000465	CcSEcCtD
Perflutren—Gastrointestinal disorder—Docetaxel—lung cancer	0.000455	0.000465	CcSEcCtD
Perflutren—Asthenia—Etoposide—lung cancer	0.000455	0.000465	CcSEcCtD
Perflutren—Connective tissue disorder—Doxorubicin—lung cancer	0.000454	0.000465	CcSEcCtD
Perflutren—Fatigue—Docetaxel—lung cancer	0.000454	0.000464	CcSEcCtD
Perflutren—Nausea—Irinotecan—lung cancer	0.000452	0.000462	CcSEcCtD
Perflutren—Pain—Docetaxel—lung cancer	0.00045	0.00046	CcSEcCtD
Perflutren—Back pain—Methotrexate—lung cancer	0.00045	0.00046	CcSEcCtD
Perflutren—Pruritus—Etoposide—lung cancer	0.000448	0.000458	CcSEcCtD
Perflutren—Visual impairment—Doxorubicin—lung cancer	0.000446	0.000456	CcSEcCtD
Perflutren—Asthenia—Paclitaxel—lung cancer	0.000446	0.000456	CcSEcCtD
Perflutren—Nausea—Gemcitabine—lung cancer	0.000441	0.00045	CcSEcCtD
Perflutren—Vomiting—Cisplatin—lung cancer	0.00044	0.000449	CcSEcCtD
Perflutren—Pruritus—Paclitaxel—lung cancer	0.000439	0.000449	CcSEcCtD
Perflutren—Vision blurred—Methotrexate—lung cancer	0.000438	0.000448	CcSEcCtD
Perflutren—Rash—Cisplatin—lung cancer	0.000436	0.000446	CcSEcCtD
Perflutren—Dermatitis—Cisplatin—lung cancer	0.000436	0.000445	CcSEcCtD
Perflutren—Feeling abnormal—Docetaxel—lung cancer	0.000434	0.000443	CcSEcCtD
Perflutren—Diarrhoea—Etoposide—lung cancer	0.000433	0.000443	CcSEcCtD
Perflutren—Eye disorder—Doxorubicin—lung cancer	0.000432	0.000442	CcSEcCtD
Perflutren—Ill-defined disorder—Methotrexate—lung cancer	0.000431	0.000441	CcSEcCtD
Perflutren—Tinnitus—Doxorubicin—lung cancer	0.000431	0.000441	CcSEcCtD
Perflutren—Gastrointestinal pain—Docetaxel—lung cancer	0.000431	0.00044	CcSEcCtD
Perflutren—Cardiac disorder—Doxorubicin—lung cancer	0.000429	0.000439	CcSEcCtD
Perflutren—Flushing—Doxorubicin—lung cancer	0.000429	0.000439	CcSEcCtD
Perflutren—Diarrhoea—Paclitaxel—lung cancer	0.000425	0.000434	CcSEcCtD
Perflutren—Angiopathy—Doxorubicin—lung cancer	0.00042	0.000429	CcSEcCtD
Perflutren—Malaise—Methotrexate—lung cancer	0.000419	0.000429	CcSEcCtD
Perflutren—Dizziness—Etoposide—lung cancer	0.000419	0.000428	CcSEcCtD
Perflutren—Immune system disorder—Doxorubicin—lung cancer	0.000418	0.000427	CcSEcCtD
Perflutren—Vertigo—Methotrexate—lung cancer	0.000418	0.000427	CcSEcCtD
Perflutren—Mediastinal disorder—Doxorubicin—lung cancer	0.000417	0.000426	CcSEcCtD
Perflutren—Body temperature increased—Docetaxel—lung cancer	0.000416	0.000425	CcSEcCtD
Perflutren—Abdominal pain—Docetaxel—lung cancer	0.000416	0.000425	CcSEcCtD
Perflutren—Leukopenia—Methotrexate—lung cancer	0.000416	0.000425	CcSEcCtD
Perflutren—Chills—Doxorubicin—lung cancer	0.000415	0.000424	CcSEcCtD
Perflutren—Arrhythmia—Doxorubicin—lung cancer	0.000413	0.000422	CcSEcCtD
Perflutren—Dizziness—Paclitaxel—lung cancer	0.000411	0.00042	CcSEcCtD
Perflutren—Nausea—Cisplatin—lung cancer	0.000411	0.00042	CcSEcCtD
Perflutren—Cough—Methotrexate—lung cancer	0.000406	0.000415	CcSEcCtD
Perflutren—Convulsion—Methotrexate—lung cancer	0.000403	0.000412	CcSEcCtD
Perflutren—Vomiting—Etoposide—lung cancer	0.000403	0.000412	CcSEcCtD
Perflutren—Erythema—Doxorubicin—lung cancer	0.000403	0.000412	CcSEcCtD
Perflutren—Rash—Etoposide—lung cancer	0.000399	0.000408	CcSEcCtD
Perflutren—Dermatitis—Etoposide—lung cancer	0.000399	0.000408	CcSEcCtD
Perflutren—Headache—Etoposide—lung cancer	0.000397	0.000406	CcSEcCtD
Perflutren—Myalgia—Methotrexate—lung cancer	0.000396	0.000405	CcSEcCtD
Perflutren—Arthralgia—Methotrexate—lung cancer	0.000396	0.000405	CcSEcCtD
Perflutren—Chest pain—Methotrexate—lung cancer	0.000396	0.000405	CcSEcCtD
Perflutren—Vomiting—Paclitaxel—lung cancer	0.000395	0.000404	CcSEcCtD
Perflutren—Dysgeusia—Doxorubicin—lung cancer	0.000394	0.000403	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000393	0.000402	CcSEcCtD
Perflutren—Rash—Paclitaxel—lung cancer	0.000392	0.0004	CcSEcCtD
Perflutren—Dermatitis—Paclitaxel—lung cancer	0.000391	0.0004	CcSEcCtD
Perflutren—Discomfort—Methotrexate—lung cancer	0.000391	0.0004	CcSEcCtD
Perflutren—Back pain—Doxorubicin—lung cancer	0.000389	0.000398	CcSEcCtD
Perflutren—Headache—Paclitaxel—lung cancer	0.000389	0.000398	CcSEcCtD
Perflutren—Hypersensitivity—Docetaxel—lung cancer	0.000388	0.000397	CcSEcCtD
Perflutren—Muscle spasms—Doxorubicin—lung cancer	0.000387	0.000396	CcSEcCtD
Perflutren—Anaphylactic shock—Methotrexate—lung cancer	0.000379	0.000388	CcSEcCtD
Perflutren—Vision blurred—Doxorubicin—lung cancer	0.000379	0.000388	CcSEcCtD
Perflutren—Asthenia—Docetaxel—lung cancer	0.000378	0.000386	CcSEcCtD
Perflutren—Nausea—Etoposide—lung cancer	0.000376	0.000385	CcSEcCtD
Perflutren—Ill-defined disorder—Doxorubicin—lung cancer	0.000374	0.000382	CcSEcCtD
Perflutren—Pruritus—Docetaxel—lung cancer	0.000372	0.000381	CcSEcCtD
Perflutren—Nervous system disorder—Methotrexate—lung cancer	0.000372	0.00038	CcSEcCtD
Perflutren—Agitation—Doxorubicin—lung cancer	0.00037	0.000378	CcSEcCtD
Perflutren—Nausea—Paclitaxel—lung cancer	0.000369	0.000377	CcSEcCtD
Perflutren—Skin disorder—Methotrexate—lung cancer	0.000369	0.000377	CcSEcCtD
Perflutren—Hyperhidrosis—Methotrexate—lung cancer	0.000367	0.000375	CcSEcCtD
Perflutren—Malaise—Doxorubicin—lung cancer	0.000363	0.000371	CcSEcCtD
Perflutren—Vertigo—Doxorubicin—lung cancer	0.000362	0.00037	CcSEcCtD
Perflutren—Syncope—Doxorubicin—lung cancer	0.000361	0.000369	CcSEcCtD
Perflutren—Leukopenia—Doxorubicin—lung cancer	0.00036	0.000368	CcSEcCtD
Perflutren—Diarrhoea—Docetaxel—lung cancer	0.00036	0.000368	CcSEcCtD
Perflutren—Palpitations—Doxorubicin—lung cancer	0.000356	0.000364	CcSEcCtD
Perflutren—Hypotension—Methotrexate—lung cancer	0.000355	0.000362	CcSEcCtD
Perflutren—Loss of consciousness—Doxorubicin—lung cancer	0.000354	0.000362	CcSEcCtD
Perflutren—Cough—Doxorubicin—lung cancer	0.000351	0.000359	CcSEcCtD
Perflutren—Convulsion—Doxorubicin—lung cancer	0.000349	0.000357	CcSEcCtD
Perflutren—Dizziness—Docetaxel—lung cancer	0.000348	0.000356	CcSEcCtD
Perflutren—Hypertension—Doxorubicin—lung cancer	0.000348	0.000355	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000346	0.000353	CcSEcCtD
Perflutren—Chest pain—Doxorubicin—lung cancer	0.000343	0.00035	CcSEcCtD
Perflutren—Arthralgia—Doxorubicin—lung cancer	0.000343	0.00035	CcSEcCtD
Perflutren—Myalgia—Doxorubicin—lung cancer	0.000343	0.00035	CcSEcCtD
Perflutren—Paraesthesia—Methotrexate—lung cancer	0.000341	0.000348	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.00034	0.000348	CcSEcCtD
Perflutren—Discomfort—Doxorubicin—lung cancer	0.000339	0.000346	CcSEcCtD
Perflutren—Dyspnoea—Methotrexate—lung cancer	0.000338	0.000346	CcSEcCtD
Perflutren—Dry mouth—Doxorubicin—lung cancer	0.000335	0.000343	CcSEcCtD
Perflutren—Vomiting—Docetaxel—lung cancer	0.000335	0.000342	CcSEcCtD
Perflutren—Dyspepsia—Methotrexate—lung cancer	0.000334	0.000341	CcSEcCtD
Perflutren—Rash—Docetaxel—lung cancer	0.000332	0.000339	CcSEcCtD
Perflutren—Dermatitis—Docetaxel—lung cancer	0.000332	0.000339	CcSEcCtD
Perflutren—Headache—Docetaxel—lung cancer	0.00033	0.000337	CcSEcCtD
Perflutren—Anaphylactic shock—Doxorubicin—lung cancer	0.000329	0.000336	CcSEcCtD
Perflutren—Oedema—Doxorubicin—lung cancer	0.000329	0.000336	CcSEcCtD
Perflutren—Gastrointestinal disorder—Methotrexate—lung cancer	0.000328	0.000335	CcSEcCtD
Perflutren—Fatigue—Methotrexate—lung cancer	0.000327	0.000334	CcSEcCtD
Perflutren—Pain—Methotrexate—lung cancer	0.000324	0.000332	CcSEcCtD
Perflutren—Shock—Doxorubicin—lung cancer	0.000323	0.00033	CcSEcCtD
Perflutren—Nervous system disorder—Doxorubicin—lung cancer	0.000322	0.000329	CcSEcCtD
Perflutren—Tachycardia—Doxorubicin—lung cancer	0.000321	0.000328	CcSEcCtD
Perflutren—Skin disorder—Doxorubicin—lung cancer	0.000319	0.000326	CcSEcCtD
Perflutren—Hyperhidrosis—Doxorubicin—lung cancer	0.000318	0.000325	CcSEcCtD
Perflutren—Nausea—Docetaxel—lung cancer	0.000313	0.00032	CcSEcCtD
Perflutren—Feeling abnormal—Methotrexate—lung cancer	0.000313	0.00032	CcSEcCtD
Perflutren—Gastrointestinal pain—Methotrexate—lung cancer	0.00031	0.000317	CcSEcCtD
Perflutren—Hypotension—Doxorubicin—lung cancer	0.000307	0.000314	CcSEcCtD
Perflutren—Urticaria—Methotrexate—lung cancer	0.000301	0.000308	CcSEcCtD
Perflutren—Body temperature increased—Methotrexate—lung cancer	0.0003	0.000307	CcSEcCtD
Perflutren—Abdominal pain—Methotrexate—lung cancer	0.0003	0.000307	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000299	0.000306	CcSEcCtD
Perflutren—Paraesthesia—Doxorubicin—lung cancer	0.000295	0.000302	CcSEcCtD
Perflutren—Dyspnoea—Doxorubicin—lung cancer	0.000293	0.000299	CcSEcCtD
Perflutren—Dyspepsia—Doxorubicin—lung cancer	0.000289	0.000296	CcSEcCtD
Perflutren—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000284	0.00029	CcSEcCtD
Perflutren—Fatigue—Doxorubicin—lung cancer	0.000283	0.00029	CcSEcCtD
Perflutren—Pain—Doxorubicin—lung cancer	0.000281	0.000287	CcSEcCtD
Perflutren—Hypersensitivity—Methotrexate—lung cancer	0.00028	0.000286	CcSEcCtD
Perflutren—Asthenia—Methotrexate—lung cancer	0.000272	0.000278	CcSEcCtD
Perflutren—Feeling abnormal—Doxorubicin—lung cancer	0.000271	0.000277	CcSEcCtD
Perflutren—Gastrointestinal pain—Doxorubicin—lung cancer	0.000269	0.000275	CcSEcCtD
Perflutren—Pruritus—Methotrexate—lung cancer	0.000268	0.000274	CcSEcCtD
Perflutren—Urticaria—Doxorubicin—lung cancer	0.000261	0.000267	CcSEcCtD
Perflutren—Abdominal pain—Doxorubicin—lung cancer	0.00026	0.000266	CcSEcCtD
Perflutren—Body temperature increased—Doxorubicin—lung cancer	0.00026	0.000266	CcSEcCtD
Perflutren—Diarrhoea—Methotrexate—lung cancer	0.00026	0.000265	CcSEcCtD
Perflutren—Dizziness—Methotrexate—lung cancer	0.000251	0.000256	CcSEcCtD
Perflutren—Hypersensitivity—Doxorubicin—lung cancer	0.000242	0.000247	CcSEcCtD
Perflutren—Vomiting—Methotrexate—lung cancer	0.000241	0.000247	CcSEcCtD
Perflutren—Rash—Methotrexate—lung cancer	0.000239	0.000245	CcSEcCtD
Perflutren—Dermatitis—Methotrexate—lung cancer	0.000239	0.000244	CcSEcCtD
Perflutren—Headache—Methotrexate—lung cancer	0.000238	0.000243	CcSEcCtD
Perflutren—Asthenia—Doxorubicin—lung cancer	0.000236	0.000241	CcSEcCtD
Perflutren—Pruritus—Doxorubicin—lung cancer	0.000232	0.000238	CcSEcCtD
Perflutren—Nausea—Methotrexate—lung cancer	0.000225	0.00023	CcSEcCtD
Perflutren—Diarrhoea—Doxorubicin—lung cancer	0.000225	0.00023	CcSEcCtD
Perflutren—Dizziness—Doxorubicin—lung cancer	0.000217	0.000222	CcSEcCtD
Perflutren—Vomiting—Doxorubicin—lung cancer	0.000209	0.000214	CcSEcCtD
Perflutren—Rash—Doxorubicin—lung cancer	0.000207	0.000212	CcSEcCtD
Perflutren—Dermatitis—Doxorubicin—lung cancer	0.000207	0.000212	CcSEcCtD
Perflutren—Headache—Doxorubicin—lung cancer	0.000206	0.00021	CcSEcCtD
Perflutren—Nausea—Doxorubicin—lung cancer	0.000195	0.0002	CcSEcCtD
